FMS as reported
Fresenius Medical Care AG reported €19.6B of revenue over the trailing twelve months, +1.5% on the year before. 10 reported series are charted on this page, each one as filed.
€19.6B
Revenue, trailing twelve months · to Q4 2025 · +1.5% against the twelve months before
- Net Income
- €978M
Net Income · +82% year on year · trailing twelve months to Q4 2025
- Op Margin
- 9.3%
Op Margin · trailing twelve months to Q4 2025
- EPS
- €3.37
EPS · +84% year on year · trailing twelve months to Q4 2025
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | €19.6B | +1.5% | Q4 2025 |
| Net Income | €978M | +82% | Q4 2025 |
| EPS | €3.37 | +84% | Q4 2025 |
| Gross Margin | 26% | n/a | Q4 2025 |
| Op Margin | 9.3% | n/a | Q4 2025 |
| Net Margin | 5.0% | n/a | Q4 2025 |
| ROE | 5.5% | n/a | Q4 2025 |
| ROA | 2.4% | n/a | Q4 2025 |
| ROIC | 6.7% | n/a | Q4 2025 |
| Free Cash Flow | €3.03B | n/a | Q4 2020 · 20 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Fresenius Medical Care AG (FMS) - Revenue & ProfitRevenue & ProfitFresenius Medical Care AG (FMS)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Care Facilities
Ranks #26 of 28 by Smart Score